Daewoong Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
106,028
182,032
152,091
160,835
147,073
132,376
Total Accounts Receivable
89,371
102,957
142,354
173,501
169,987
178,938
Inventories
115,144
111,864
144,508
162,746
187,016
189,035
Other Current Assets
1,576
6,934
14,151
10,377
14,056
15,316
Total Current Assets
312,120
403,787
453,105
507,459
518,132
515,666
Net Property, Plant & Equipment
132,623
160,110
255,844
367,080
396,158
401,129
Total Investments and Advances
102,106
97,644
97,518
105,547
103,333
111,867
Long-Term Note Receivable
-
-
118
2,907
2,808
7,405
Intangible Assets
27,760
31,410
136,722
151,001
173,975
149,574
Other Assets
4,404
1,014
2
4,767
4,512
4,310
Total Assets
579,013
694,264
944,529
1,144,700
1,213,525
1,207,846
ST Debt & Current Portion LT Debt
3,003
4,851
47,443
107,753
95,726
Accounts Payable
35,521
36,487
45,467
61,381
59,441
Income Tax Payable
14,101
237
7,201
4,296
6,901
Other Current Liabilities
34,572
38,104
49,325
49,402
105,980
Total Current Liabilities
87,197
79,680
149,437
222,832
268,049
Long-Term Debt
39,866
139,512
189,410
289,165
289,336
Provision for Risks & Charges
5,103
10,047
3,276
5,290
5,013
Deferred Taxes
106
300
8,800
3,181
6,416
Other Liabilities
8,778
9,518
12,146
13,741
11,399
Total Liabilities
141,050
238,758
364,288
540,149
581,988
Common Equity (Total)
433,672
443,080
480,072
499,493
519,439
Total Shareholders' Equity
433,672
443,080
480,072
499,493
519,439
Total Equity
437,963
455,506
580,241
604,551
631,537
Liabilities & Shareholders' Equity
579,013
694,264
944,529
1,144,700
1,213,525
Accumulated Minority Interest
4,291
12,426
100,169
105,058
112,098
About Daewoong Pharmaceutical Co.
View Profile
